Opinion
20-CV-08255 (PMH)
11-17-2022
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC., Plaintiff, v. REGENERON PHARMACEUTICALS, INC., Defendant.
ORDER
PHILIP M. HALPERN, UNITED STATES DISTRICT JUDGE
On November 16, 2022, counsel for Defendant Regeneron Pharmaceuticals, Inc. wrote to the Court, with Plaintiff Allele Biotechnology and Pharmaceuticals, Inc.'s consent, requesting that each party be allotted up to 75 minutes for the claim construction hearing scheduled for November 21, 2022 at 10:30 a.m. That application is denied. The Court will endeavor to spend as much time as necessary to consider each party's position.
SO ORDERED.